Calpain inhibition rescues troponin T3 fragmentation, increases Cav1.1, and enhances skeletal muscle force in aging sedentary mice by Zhang, Tan et al.
Calpain inhibition rescues troponin T3 fragmentation, increases
Cav1.1, and enhances skeletal muscle force in aging sedentary
mice
Tan Zhang,1,2 Andrea S. Pereyra,1* Zhong-Min Wang,1
Alexander Birbrair,1† Julie A. Reisz,2‡ Daniel Clark Files,3 Lina
Purcell,3 Xin Feng,4 Maria L. Messi,1 Hanzhong Feng,5 Joseph
Chalovich,6 Jian-Ping Jin,5 Cristina Furdui2 and Osvaldo
Delbono1,7
1Department of Internal Medicine, Section on Gerontology and Geriatric
Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA
2Molecular Medicine and Translational Science, Wake Forest School of
Medicine, Winston-Salem, NC, USA
3Pulmonary, Critical Care, Allergy and Immunologic Diseases, Wake Forest
School of Medicine, Winston-Salem, NC, USA
4Department of Otolaryngology, Wake Forest School of Medicine, Winston-
Salem, NC, USA
5Wayne State University School of Medicine, Detroit, MI, USA
6Department of Biochemistry and Molecular Biology, Brody School of
Medicine, East Carolina University, Greenville, NC, USA
7J Paul Sticht Center on Aging, Wake Forest School of Medicine, Winston-
Salem, NC, USA
Summary
Loss of strength in human and animal models of aging can be
partially attributed to a well-recognized decrease in muscle mass;
however, starting at middle-age, the normalized force (force/
muscle cross-sectional area) in the knee extensors and single
muscle fibers declines in a curvilinear manner. Strength is lost
faster than muscle mass and is a more consistent risk factor for
disability and death. Reduced expression of the voltage sensor
Ca2+ channel a1 subunit (Cav1.1) with aging leads to excitation–
contraction uncoupling, which accounts for a significant fraction
of the decrease in skeletal muscle function. We recently reported
that in addition to its classical cytoplasmic location, fast skeletal
muscle troponin T3 (TnT3) is fragmented in aging mice, and both
full-length TnT3 (FL-TnT3) and its carboxyl-terminal (CT-TnT3)
fragment shuttle to the nucleus. Here, we demonstrate that it
regulates transcription of Cacna1s, the gene encoding Cav1.1.
Knocking down TnT3 in vivo downregulated Cav1.1. TnT3
downregulation or overexpression decreased or increased,
respectively, Cacna1s promoter activity, and the effect was
ablated by truncating the TnT3 nuclear localization sequence.
Further, we mapped the Cacna1s promoter region and estab-
lished the consensus sequence for TnT3 binding to Cacna1s
promoter. Systemic administration of BDA-410, a specific calpain
inhibitor, prevented TnT3 fragmentation, and Cacna1s and Cav1.1
downregulation and improved muscle force generation in seden-
tary old mice.
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Introduction
Aging is associated with loss of muscle strength and power that
contributes to fall risk, impaired mobility, and reduced quality of life
(Alley et al., 2010). Besides its recognized role in mobility, posture, heat
regulation, and endocrine function, the skeletal muscle plays a central
role in whole body metabolism, which affects systemic aging and
lifespan (Demontis et al., 2013). Cohort studies show that strength is
lost two- to five-times faster than muscle mass with age (Goodpaster
et al., 2006), and its loss is a more consistent risk factor for disability and
death (Newman et al., 2006). Although muscle mass is one determinant
of strength, its loss does not fully account for aging-related strength loss
(Rolland et al., 2007). Therapies that increase not only muscle mass but
muscle strength, power, and quality (strength per unit of mass) would
greatly benefit the health of older adults.
Our laboratory and others reported that aging impairs muscle
activation–contraction efficiency (Delbono, 2011). Altered transmittal
of membrane depolarization to SR Ca2+ release decreases force-
generation capacity in old rodents and humans (Wang et al., 2000).
The molecular mechanism responsible for the loss of muscle-contraction
efficiency is decreased voltage-gated calcium channel a1 subunit
(Cav1.1) (Renganathan et al., 1997). It is essential for muscle contraction
and, with aging, uncouples more ryanodine receptors (RyR1s) through
an undefined mechanism.
In the myoplasm, troponin T (TnT) is known to mediate the interaction
between the Tn complex and tropomyosin (Tm), which is essential for
Ca2+-activated striated muscle contraction (Jin et al., 2008). We
reported a noncanonical role for TnT3, the TnT isoform expressed in
fast-twitch muscle fibers. We found full-length (FL)-TnT3 and its
fragments in both the nuclear and cytosolic fractions of myofibers
isolated from mouse skeletal muscle. More important, the myonuclei of
old mice had less of the full-length protein and more of the COOH-
terminal (CT) fragment (TnCT) than those of young mice (Zhang et al.,
2013a,b). Whether TnT3 regulates expression of Cav1.1 in muscle in vivo
is unknown.
Calpains are a family of calcium-dependent cysteine endopeptidases.
The skeletal muscle contains ubiquitous calpain-1 (l-type) and calpain-2
(m-type), and muscle-specific calpain-3. Calpain-1 mediates proteolysis
of various cellular proteins, including cytoskeletal proteins (Campbell &
Davies, 2012). Calpain-1 overactivation causes irreversible cell damage,
contributing to the pathology of cerebral and cardiac ischemia,
Alzheimer’s disease, arthritis, and cataracts (Wang & Yuen, 1994; Lee
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et al., 2000). Calpains may be activated by muscle microinjuries
throughout the lifespan, particularly at later stages, when increased
susceptibility to trauma may activate calpains (Faulkner et al., 1993;
Salazar et al., 2010).
In this study, we proved our hypothesis that TnT3 regulates Cav1.1
expression in fast adult myofibers. Decreased nuclear FL-TnT3 and
increased CT-TnT3 fraction result in decreased expression of Cacna1s,
the gene encoding Cav1.1, and impaired excitation–contraction cou-
pling (ECC) with aging. They can be rescued in sedentary old mice by
systemic administration of BDA-410, a specific calpain inhibitor, which
prevents TnT3 fragmentation.
Results
TnT3 regulates Cacna1s transcription and Cav1.1 expression
To test whether TnT3 regulates Cacna1s transcription, we knocked
down TnT3 in mouse skeletal muscle in vivo to determine whether
Cav1.1 expression depends on TnT3 regulation of Cacna1s. We
compared flexor digitorum brevis (FDB) muscles 3 weeks after
electroporation with control nontargeting (shC) or targeting TnT3
shRNA (shT) by immunoblot, and quantitative real-time PCR (qPCR)
(Fig. 1A–C). shT’s efficiency in knocking down TnT3 was confirmed by
immunoblot (Fig. 1A,B), which showed an over 70% (P < 0.05)
decrease in endogenous TnT3 expression. Using this preparation, we
found that Cav1.1 was reduced by ~ 60% (P < 0.05) due to
downregulation of Tnnt3 (P < 0.01) and Cacna1s (P < 0.05) mRNA
(Fig. 1C).
To examine the hypothesis that TnT3 regulates Cacna1s transcription,
we performed a dual luciferase assay using a construct in which the
Cacna1s promoter drives the firefly luciferase reporter gene (Zheng
et al., 2002a). We analyzed C2C12 myotubes transfected with shC or
shT at day 5 in differentiation medium (DM) (Fig. 1D), when Cacna1s
promoter activity peaks (Zheng et al., 2002a). The shT effectively
knocked down TnT3 but not myosin heavy chain (MHC) protein levels
(Fig. 1E); accordingly, Cacna1s promoter activity was inhibited (Fig. 1G),
while myotube formation and differentiation capacity, reflected by the
fusion index and MHC level, respectively, was not altered significantly
(Fig. 2E,F). Compared to control DsRed, TnFL-DsRed but not the nuclear
localization signal (NLS)-deletion construct TnFL-DNLS/DsRed or the
leucine zipper domain (LZD)-deletion construct enhanced Cacna1s
promoter activity in mouse FDB muscle in vivo (Fig. 2H–I). These results
indicate that (i) TnT3 enhances Cacna1s promoter activity, (ii) TnT3
knockdown directly reduces Cacna1s promoter activity in skeletal
muscle, and (iii) preventing TnT3’s nuclear translocation inhibits its
effect on Cacna1s transcription.
TnT3 interacts with the Cacna1s promoter region
Next, we examined TnT3 recruitment onto the Cacna1s promoter using a
ChIP-based promoter walkthrough analysis. We tested eight pairs of PCR
primers, covering the full-length of the Cacna1s promoter region
(1081 to +109), and found three regions (P4, P5, and P8) that may
recruit TnT3 (Fig. 1J,K). As P5 contains an E-box motif, which is known
to interact with a leucine zipper domain (Vinson et al., 1989) that is
found in TnT3 (Zhang et al., 2013a), we explored whether TnT3 directly
binds this region. We used an electrophoretic mobility shift assay (EMSA)
and the IRDye700-labeled double-stranded oligonucleotide (Cacna1s
451 to 381) containing an E-box (Fig. 2A). When incubated with
TnT3 purified from mouse tibialis anterior muscle, the IRDye700-labeled
wild-type 170-bp probe exhibited gel shift, which was inhibited by
adding 200-fold molar excess of unlabeled oligonucleotides. The shift
was consistently attenuated by adding a TnT3-specific antibody during
incubation. In contrast, two other oligonucleotides containing sequences
other than the Cacna1s promoter’s showed no gel shift in the presence
of TnT3 (lanes 5–8) (Fig. 2B).
To rule out any contribution from TnI, TnC, and/or Tm contaminat-
ing the EMSA signal, we performed these experiments with their
respective antibodies. In contrast to the TnT3 Ab, they did not
attenuate the TnT3/P5 oligonucleotide interaction (Fig. 2B,C). These
results demonstrate the specificity of TnT3 binding to the Cacna1s
promoter region (451 to 381) and its independence from Tn-Tm
complex formation.
Establishing that TnT3 is recruited to the Cacna1s P4, P5, and P8
promoter regions by ChIP-PCR (Fig. 1L), we next used sequence
alignment to explore their conserved consensus binding motifs. From
the six identified, three complete consensus motifs (Fig. S1) were found
in the P5 probe (451 to 381) and P4 and P8 regions (blue box in
Fig. 2D). EMSA analysis of a further truncated P5 probe showed that
TnT3 binds to the P5a region (451 to 423) (Fig. 2E,F). E-box
mutation (P5c) or deletion (P5a) did not affect TnT3 binding, and P5b
(417 to 381) did not seem to play a major role in TnT3 binding
(Fig. 2E,F). These data map the TnT3-specific binding sequence to the
451 to 423 Cacna1s promoter region, which contains consensus
motif 6 and part of 3. Mutation of either motif inhibited TnT3-induced
gel shift (Fig. 2G,H), indicating that TnT3 binds to each independently.
TnT3 binding to the Cacna1s promoter region is consistent with our
previous report that most transcription factor binding sites are located
within 1 kb upstream of the Cacna1s’ transcription start site (Zheng
et al., 2002b).
The TnT3 endogenous cleavage site in muscle in vivo is
compatible with calpain activity
Figure S2A shows SDS-PAGE separation of nuclear protein extracted
from old mice in two lanes, one stained on gel with Coomassie blue,
while the other was transferred to a PVDF membrane and immunoblot-
ted. This TnT3 fragment corresponds to CT-TnT3 (red box in gel and
yellow box in immunoblot) as confirmed by mass spectrometry
sequence analysis. The relative position of the CT-TnT3 fragment in
nuclear extracts was also determined with reference to the protein
ladder. Figure S2B shows mass spectrometry analysis of trimethox-
yphenyl phosphonium (TMPP)-labeled nuclear protein extracts. TMPP-
labeled TnT3 N-terminal amino acids are shown in red. GPS-CCD 1.0
(Liu et al., 2011) indicates that two of three of the TMPP-labeled sites
are calpain cleavage sites.
BDA-410 inhibits endogenous skeletal muscle calpain activity
As calpain may be the enzyme that endogenously cleaves TnT3, we
asked whether BDA-410, a potent and selective inhibitor of calpain
protease activity, would significantly reduce skeletal muscle calpain
activity. Figure S3A shows that BDA-410 significantly reduces AMC
(7-amino-4-methylcoumarin) cleavage. In mouse muscles treated with
either vehicle (B) or BDA-410 (C), enzyme activity was significantly
decreased in the presence of calpain inhibitor III (B). Note that the BDA-
410-treated muscles showed less enzyme activity than vehicle-treated
muscles in the absence of inhibitor (C), while in its presence, AMC
activity was similar (B, C). These results indicate that BDA-410 potently
blocks endogenous calpain activity.
Calpain, troponin and muscle function with aging, T. Zhang et al. 489
ª 2016 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
Calpain inhibition enhances muscle force, but not fatigue, in
old mice
For these experiments, we chose the soleus muscle, which, unlike fast
hindlimb muscles, is a mixture of fast and slow fibers and, in
correlation with histology, can clarify any functional impact of changes
in fiber-type composition. Soleus muscle absolute force was signifi-
cantly enhanced at submaximal and maximal stimulation rates in mice
treated with BDA-410 rather than vehicle (Fig. 3A,B). This stimulatory
effect was not associated with increased muscle cross-sectional area
(CSA) (C), which indicates that the increase in muscle absolute force
was due to increased efficiency, not protein accrual. The significant
increase in specific force at the same stimulation frequency range in
mice treated with BDA-410 rather than vehicle further supports this
conclusion (D, E).
Analysis of the contractile properties of the soleus and triceps surae
muscles, using comparable protocols, showed no difference in the
fatigue index either ex vivo or in vivo (Fig. S4A,B). We confirmed that
BDA-410 had no effect on muscle endurance by measuring the maximal
tolerated speed in a forced treadmill (C). In contrast, inverted-cling grip
holding time, a measurement of strength, was significantly increased in
BDA-410 compared to vehicle-treated mice (D).
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Fig. 1 TnT3 knockdown in vivo decreases Cav1.1 and Cacna1 expression; its overexpression enhances Cacna1s promoter activity in C2C12 and mouse muscle in vivo; and it
is recruited onto the Cacna1s promoter. (A) Representative immunoblot of protein extracts from shC- and shT-electroporated FDB muscles. (B) Quantification of 3
independent immunoblots, showing that shT decreases TnT3 and Cav1.1. (C) Quantitative qRT–PCR showing that shT successfully knocked down Tnnt3 mRNA, which
resulted in downregulation of Cacna1s. *P < 0.05, **P < 0.01. (D) Cultured C2C12 cells transfected with shC or shT did not show differences in myotube formation at day
5 day in DM. (E) Immunoblot of total protein extracts. Compared to shC-, shT-transfected C2C12 myotubes show strong TnT3, but not MHC, knockdown. PVDF membrane
stained with Ponceau S indicates the same total protein loading. (F) Fusion index shows that shT treatment did not prevent C2C12 myoblast fusion at day 5 in DM. (G)
Luciferase activity assay, expressed as the firefly/renilla ratio, shows that knocking down TnT3 inhibits Cacna1s promoter activity in C2C12 cells at day 5 in DM. (*P < 0.05,
**P < 0.01). (H) Diagram of nuclear localization sequence (NLS) and leucine zipper domain (LZD) deletion in the full-length TnT3 (TnFL)-DsRed fusion construct. (I) Raw
normalized data comparing luciferase activity for TnFL, TnFL-DLZD/DsRed, TnFL-DNLS/DsRed, and DsRed. Differences between these individual groups and DsRed are noted
by their level of significance (*) P < 0.05 or (**) P < 0.005. (J) Primer set used to amplify mouse Cacna1s promoter regions that may interact with TnT3. Numbers indicate
distance from the transcription start site. Eight primer pairs were designed to walk along regions P1-P8. (K) Representative ChIP-PCR experiment in C2C12 myotubes
showing Cacna1s promoter regions recruiting endogenous TnT3. IgG was used as a control.
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Calpain inhibition does not modify the overall levels of main
motor and regulatory proteins or fiber type in fast and slow
muscles from old mice
Figure 4 shows that BDA-410 does not modify EDL and soleus fiber-type
composition (IIa, IIx, IIb, and I) (A, B, E, F) or titin protein levels (C, D).
Figure S5 shows that calpain inhibition does not modify the levels of
myosin heavy chain (MHC) and actin or their ratio in either soleus (A) or
EDL (B) muscles from BDA-410- and vehicle-treated mice (C). Figure S6
shows that calpain inhibition does not modify total fast or slow troponin
T or troponin I. Total fast and slow TnT and TnI protein levels measured
by immunoblot in soleus (A, B, E) and EDL (C-D, F) muscles. Overall,
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Fig. 2 EMSA mapping of the Cacna1s promoter region that interacts with TnT3. (A) EMSA oligonucleotide designed to test the proximal half of the Cacna1s promoter’s P5
region and used in subsequent experiments. (B) Compared to oligos alone (lane 1), TnT3 induces a band shift (lane 2) that is attenuated by unlabeled oligos (lane 3) and pre-
incubation with TnT3 and TnT3 antibody (lane 4). Two oligos, designated control- and control-2 (Table S1), unrelated to Cacna1s, show no binding to TnT3 (lanes 4–8). (C)
Compared to P5 oligos alone (lane 1), TnT3 induced a band shift (lane 2) that was attenuated by unlabeled oligos (lane 3). In contrast, TnI, TnC, and Tm antibodies and
mouse (m) and rabbit (r) IgG did not attenuate band shift as shown in a separate gel. (D) Multiple EM for Motif Elicitation (MEME) (Bailey et al., 2006) sequence alignment
and comparison of P4, P5, and P8 regions. The six consensus motifs identified are highlighted. The blue box encloses the Cacna1s promoter region that interacts with TnT3 in
the ChiP assay. (E) Oligonucleotide design, based on MEME, identified motifs in the P5 proximal half region. P5a is the sequence upstream the E-box (in black); P5b is the
sequence downstream of the E-box; and P5c is the E-box in the mutated full-length P5. (F) Representative EMSA data show that P5b has the weakest binding to TnT3, while
P5a shows strong binding. The E-box does not seem required for TnT3 binding because both P5c (E-box mutant) and P5a (sequence upstream of E-box) clearly bind to TnT3.
(G) Diagrams showing oligos with mutated P5a-R3 (P5a-R3 m) or P5a-R6 (P5a-R6 m). H) Representative EMSA data showing that both R3 and R6 mutations diminished the
gel shift of P5a oligos.
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these results indicate that increased muscle force in response to calpain
inhibition cannot explained by main motor and regulatory protein
accrual or switch in fiber-type composition.
BDA-410 stabilizes nuclear TnT3 integrity in skeletal muscle from old
mice in vivo
In contrast to old mice treated with vehicle only, those treated with BDA-
410 had significantly lower levels of TnCT (Fig. 5A,B), while the TnNT
fraction normalized to the nuclear protein marker histone H3 protein or
TnFL normalized to tubulin (D-E) did not differ significantly (C). Lack of
change in total TnT protein levels (Fig. S6), despite decreased TnT3
fragmentation induced by BDA-410 (Fig. 5A,B), is explained by the
abundance of myofilament-attached TnFL (Zhang et al., 2013a) and its
dominance in immunoblot assays.
Calpain inhibition rescues Cav1.1 protein levels in old mice
Figure 6A shows that Cav1.1 expression normalized to GAPDH is
significantly higher in old mice treated with BDA-410 rather than
vehicle (P < 0.05). Thus, TnT3 fragmentation impairs Cacna1s tran-
scription and Cav1.1 expression (Fig. 1), and BDA-410-mediated calpain
inhibition rescues Cav1.1 levels in skeletal muscle from aging sedentary
mice.
Discussion
Here, we report three novel findings: (i) TnT3 regulates Cacna1s
transcription and Cav1.1 expression in skeletal muscle fibers; (ii)
calpain-mediated decreased nuclear FL-TnT3, and increased CT-TnT3
fragment leads to decreased Cacna1s expression and impaired ECC; and
(iii) systemic administration of BDA-410 prevents TnT3 fragmentation
and Cav1.1 downregulation in sedentary old mice.
Tropomyosin (TM)-binding troponin (TnT) together with the calcium-
binding troponin C (TnC) and the inhibitory subunit troponin I (TnI) form
a complex that regulates muscle contraction. Specifically, it interacts
with actin and binds calcium to trigger production of muscle force
(Gordon et al., 2000). In addition to this classical cytoplasmic location
and function, the fast skeletal muscle TnT3 shuttles to the nucleus
(Zhang et al., 2013a), and because it has a DNA-binding domain (Zhang
et al., 2013a), we hypothesized that TnT3 plays a nonclassical role in
gene transcription. Recent publications show that TnI, TnT, Tm, and
other cytoskeletal proteins shuttle to the nucleus in various cells. As
TnT3, TnT1, and TnT2 exhibit a classical LZD (Vinson et al., 1989), TnT1
and TnT2 may have a nuclear function similar to that described for TnT3
in the present study. TnI has been reported in the nucleus of Drosophila
nonmuscle cells (Sahota et al., 2009) and TnI and TnT in rat and human
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Fig. 3 BDA-410 increases ex vivo isometric
contraction force in the soleus muscle. (A)
Absolute force production in response to
supramaximal stimulation at 1, 5, 10, 20,
50, 100 and 150 Hz. (B) Relative increase in
absolute force in BDA-410 compared to
vehicle-treated mice. (C) Soleus muscle
cross-sectional area (CSA). (D) Soleus
muscle-specific force calculated as the
absolute force normalized to muscle CSA.
(E) Relative increase in specific force in BDA-
410 compared to vehicle-treated mice. A
and B: *P < 0.01. D and E: *P ≤ 0.003. Left
and right soleus muscles were included in
the analysis. Data values are expressed as
mean  SEM. n = 6 for each group.
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cardiomyocytes (Asumda & Chase, 2012); however, their function in
these locations is largely unknown. We consistently demonstrated that
the nonmyofilament-associated fast skeletal muscle TnT3 enters the
nucleus through a COOH-terminus nuclear localization sequence (NLS),
KLKRQK (Zhang et al., 2013a). Here, we demonstrate that TnT3
regulates gene transcription, playing a heretofore unknown role in
nuclear signaling. We mapped the Cacna1s promoter region and
established that TnT3 is recruited to and strongly binds its P5a region.
Future ChIP-sequence analysis will investigate whether other genes share
the Cacna1s consensus sequence for TnT3 binding.
We also report here that the TnT3 endogenous cleavage site in
muscle in vivo is compatible with calpain activity, which may be subtle
and recurrent rather than massive because calpain inhibition significantly
modified TnT3 fragmentation but not overall levels of TnT3 or major
motor proteins as our analysis of myosin isoforms, actin, and titin shows.
Thus, increased muscle susceptibility to trauma with aging (Faulkner
et al., 1993) may involve calpain activation. Although TnCT contains a
leucine zipper domain and therefore retains its capacity to bind DNA, it is
likely to be less effective transcriptionally than TnFL due to its altered
conformation (Wei & Jin, 2011), a key factor in protein/DNA interactions.
Our studies indicate that TnT3-mediated Cacna1 transcription is a
primary but not the only mechanism regulation Cav1.1 expression (Zheng
et al., 2002b). Restoring nuclear levels of FL-TnT3 by calpain inhibition
significantly recovers Cav1.1 expression but we do not know how
completely. Recently, we demonstrated that increased Cavb1a expres-
sion contributes to decreased Cav1.1 expression and muscle weakness
with aging; however, the underlyingmechanism is not gene transcription,
because in young mice, Cav1.1 mRNA does not decline with Cavb1a
overexpression (Taylor et al., 2009). We also demonstrated that JP45
regulates Cav1.1 expression through a mechanism independent of gene
A B
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Fig. 4 Calpain inhibition does not modify
EDL and soleus fiber-type composition or
titin protein levels. Titin and MHC isoforms
(IIa, IIx, IIb, and I) in soleus (A) and EDL (B)
muscles measured in 5 mice treated with
BDA-410 and 4 treated with vehicle.
Differences were not statistically significant
(C–F).
Calpain, troponin and muscle function with aging, T. Zhang et al. 493
ª 2016 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
transcription (Delbono et al., 2007, 2012). Aging skeletal muscle
undergoes chronic denervation, but whether that accounts for the
accumulation of nuclear TnCT remains to be examined.
Endogenous skeletal muscle calpain activity is inhibited by systemic
administration of BDA-410 in aging sedentary mice. BDA-410 is a
synthetic Leu-Leu peptidomimetic that significantly attenuates various
disease conditions (Carragher, 2006), including memory and synaptic
transmission in a mouse model of Alzheimer disease and signs of
premature aging in a mouse model of kotho deficiency (Manya et al.,
2002; Trinchese et al., 2008). BDA-410 strongly and reversibly inhibits
cysteine proteases but not serine or aspartic proteinases. Its cyclo-
propenone group attracts the hydrogen of the –SH residues of cysteines
contained in the calpain molecule (Nabeshima et al., 2014). BDA-410-
induced calpain inhibition stabilizes nuclear TnT3 integrity and Cav1.1
protein levels in skeletal muscle in vivo and enhances muscle force, but
not fatigue, in old mice, which is at least partially explained by its lack of
effect on fiber type.
TnT3 is a master regulator of the two major calcium systems that
mediate muscle mechanical output, contractile protein function and
ECC. Publications from our laboratory and others indicate that weakness
in old age is the result of decreased muscle mass and muscle-specific
force (force/CSA) (Delbono, 2003, 2011). BDA-410 increases force
development in soleus muscle, which is a ~ 50/50 mixture of fast and
slow fibers, and because TnT3 is only expressed in fast fibers (type-II), we
predict a larger effect on pure fast-twitch muscles, such as EDL and
tibialis anterior. The improved function is associated with enhanced
contraction efficiency but no change in muscle CSA. Hence, impaired
intrinsic force-generating capacity with age may be partially due to
alterations in ECC (Tang et al., 2011). We (Renganathan et al., 1997)
and others (Ryan et al., 2000) reported diminished Cav1.1 expression
with aging, which increases uncoupled RyR1s and decreases sarcoplas-
mic reticulum Ca2+ release, leading to excitation–contraction uncou-
pling. Here, we postulate that increased TnCT and decreased TnFL in the
nucleus impair Cacna1s transcription, reducing muscle force in aging
sedentary mice. Our results also support the potential benefits of a short
trial to determine whether calpain inhibition increases muscle force in
older sedentary humans.
Experimental procedures
Mice
Old (23–25 months) female C57BL/6 mice were obtained from the
National Institute on Aging (NIA), and housed in the pathogen-free
Animal Research Program of WFSM at 20–23 °C and 12:12-h dark–light
cycle. The mice were fed ad libitum and had continuous access to
drinking water. Mice were sacrificed by decapitation with a guillotine
and thoroughly inspected for gross pathology. Animal handling and
procedures followed a protocol approved by the WFSM Animal Care and
Use Committee.
Cell culture and transfection
The mouse muscle cell line C2C12 was cultured as described (Zhang
et al., 2013a,b). Briefly, C2C12 myoblasts were plated on tissue culture
dishes or glass coverslips coated with 0.5% gelatin in growth medium
(GM) consisting of Dulbecco’s modified Eagle medium (DMEM, 1 g L1
glucose) containing 10% FBS (Atlanta Biologicals, Atlanta, GA, USA) and
2 mM Glutamax (Invitrogen, Carlsbad, CA, USA). To induce differenti-
ation and myotube formation, cells were switched to low serum
differentiation medium (DM, 2% horse serum) and cultured for
3–5 days. Lipofactamine 2000 (Invitrogen) was used for cell transfection.
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Fig. 5 BDA-410 stabilizes nuclear TnT3
integrity in old mice skeletal muscle in vivo.
(A) Immunoblot of nuclear protein
extractions from old mice treated with
BDA-410 or vehicle. CT-TnT3 and TnNT
were detected with antibodies targeting
the C- or N-terminal regions of TnT3.
Histone H3 antibody was used to detect H3
as an internal nuclear protein loading
control. (B) BDA-410 effectively reduced
the abundance of nuclear CT-TnT3
(*P < 0.05), but not TnNT normalized to H3
(C) or TnFL normalized to tubulin (D–E).
Fig. 6 Cav1.1 protein levels are higher in old mice treated with BDA-410 than
with vehicle. (A) Cav1.1 and GAPDH immunoblot in pooled hindlimb muscles from
old mice treated with either BDA-410 (n = 3) or vehicle (n = 3). (B) Cav1.1
expression, normalized to GAPDH, analyzed by densitometry, is significantly higher
in the old mice treated with BDA-410 (*P < 0.05).
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RNA extraction, reverse transcription, and qPCR
Trizol reagent (Invitrogen) was used to extract total RNA from young and
old mouse FDB muscles. Gene expression was analyzed by qPCR using
Mx3000 (Stratagene, La Jolla, CA, USA). To determine TnT3 and GAPDH
tissue expression, 10 ng of the total RNA was added to the PCR reaction
tube with qRT–PCR master mix, Taqman primer/probes (Applied
Biosystems, Foster City, CA, USA), superscript III reverse transcriptase
(Invitrogen), and RNAse inhibitor (Promega, Fitchburg, WI, USA). The
total reaction volume was 25 lL. The PCR parameters were 48 °C,
45 min 9 1 cycle; 95 °C, 10 min 9 1 cycle; 95 °C, 15 s 9 1 cycle; and
60 °C, 1 min 9 40 cycles.
Dual luciferase assay
To measure Cacna1s promoter activity, a dual luciferase assay was
carried out as described (Zheng et al., 2002a). Briefly, C2C12 cells were
plated in GM on 35-mm dishes (2 9 104 cells per dish) until reaching
70% confluence. For cell transfection, a mixture of 2 lg of Cacna1s D2
promoter (Zheng et al., 2002a), 2 lg of either control shRNA (shC) or
TnT3-targeting shRNA (shT) plasmid, and 200 ng of the control vector
pRL-TK (Promega) was exposed to Lipofectamine 2000 following the
manufacturer’s protocol. Cells were cultured in DM for 5 days to induce
differentiation before whole cell lysis. To perform the dual luciferase
assay in muscle in vivo, 10 lg of Cacna1s D2 promoter, 0.6 lg
of control vector pRL-TK, and 10 lg of DsRed constructs (DsRed,
TnFL/DsRed, or TnFL-dNLS/DsRed) were mixed and electroporated into
the FDB muscle as described (Zhang et al., 2013b). Three weeks later,
FDB muscles were dissected, and cell lysis was induced using a passive
lysis buffer (Promega). Luciferase and renilla activity were measured
using a luminometer (Turner 20E, Sunnyvale, CA, USA). Values for the
luciferase assay were normalized to renilla luciferase activity to minimize
differences in the transfection efficiency of each experiment.
TnT3 purification from mouse skeletal muscle
TnT was purified using following previous methods (Eisenberg & Kielley,
1974) with some modifications. After dissection, the homogenized TA
muscle was washed 5–6 times with 50 mM KCl, 5 mM Tris pH 8, 1%
Triton X-100, 0.5 mM, phenylmethylsulfonyl fluoride, and 1 protease
inhibitor tablet (SigmaFASTTM; Sigma-Aldrich, St. Louis, MO, USA) per
25 mL of buffer. The residue was further washed three times with
ethanol and three times with acetone. The powder was allowed to dry in
a fume hood and then stored at 20 °C until needed. The residue was
extracted for 8 h at 5 °C with 15 mL g1 residue of 1 M KCl, 25 mM Tris
pH 8, 0.1 mM CaCl2, 0.1 mM dithiothreitol, and one protease inhibitor
tablet per 25 mL. Following centrifugation, the supernatant was loaded
onto a 1-mL hydroxylapatite column equilibrated in 1M KCl and 10 mM
sodium phosphate (pH 6.8). The column was washed with 3 volumes of
the start buffer and troponin was eluted with 2 volumes of buffer with
66 mM Pi. Eluted samples were kept at 80 °C for later use. Eluted
protein (3 lg) was used in each reaction subjected to EMSA.
N-terminal protein coupling with TMPP followed by 1D SDS-
PAGE separation and mass spectrometry
Nuclear protein (NP) extractions (100 lg) were precipitated with
methanol/chloroform. Precipitates were resuspended in 200 lL labeling
buffer (50 mM Tris-HCl, 8 M urea, 2 M thiourea, pH 8.2, 1 mM
phenylmethylsulfonyl fluoride, 1 mM EDTA, 5 mM TBP, protease inhibitor
mixture, 10% CH3CN, 1% SDS). The proteins were labeled by adding
1.6 lL of 0.1 M of TMPP-Ac-OSu in CH3CN:water (2:8, v/v). After a quick
mix, the reaction was maintained at room temperature for 1 h. Residual
derivatizing reagent was quenched by adding 5 lL of 0.1 M hydroxy-
lamine, quick mixed and incubated at room temperature for 1 h. Finally,
22.8 lL glycerol was added to reach a concentration of 10%. Each
mixture of proteins (TMPP-derivatized and nonlabeled NPs) was sepa-
rated on a 12% 1D SDS-PAGE. The gel was stained with Coomassie
blue. Bands that are matched to the TnCT region (predetermined by
immunoblot) were excised, processed with tryptic digestion and then
analyzed by mass spectrometry using a Thermo LTQ Orbitrap Velos Pro
high-resolution mass spectrometer interfaced with a splitless multidi-
mensional nanoLC system (Thermo Fisher, Waltham, MA, USA/Dionex,
Sunnyvale, CA, USA) (Suh et al., 2010). Raw data files were searched
against the mouse proteome using the Mascot search engine and
PROTEOME DISCOVERER v. 1.4 (Thermo Fisher).
Electrophoretic mobility shift assay
To verify direct interaction between TnT3 protein and the Cacna1s
promoter region, Electrophoretic mobility shift assay (EMSA) was
performed according to the protocol described in the Odyssey Infrared
EMSA kit. Briefly, 3 lg of purified TnT3 was incubated with synthesized
oligo nucleic acids labeled with fluorescent IRdye700 (LI-COR Bio-
sciences, Lincoln, NE, USA). Oligo nucleic acids of the same sequence but
without a dye label were used at a concentration 200-fold higher in
competition experiments, and TnT3 antibody was used in a supershift
assay. The oligos (Table S1) were selected based on our reported
Cacna1s promoter sequence (Zheng et al., 2004) and our chromatin
immunoprecipitation data. After the binding reaction, the mixture was
loaded onto a Mini-PROTEAN TBE precast gel (5%; Bio-Rad, Hercules,
CA), run in 0.5% TBE at 70V for 1 h, and then imaged directly with an
Odyssey Infrared Imager (LI-COR Biosciences).
Microscopy and image analysis
C2C12 cells cultured on coverslips, fixed with 4% paraformaldehyde for
15 min, and their membranes permeabilized for 5 min with 0.5% Triton
X-100 in PBS buffer at RT. After three washes with PBS, cells were
incubated for 1 h in blocking buffer (PBS with 10% normal goat serum
[Sigma, St. Louis, MO, USA]) and labeled with primary and secondary
antibodies for 2 and 1 h, respectively. Cells were counterstained with
Hoechst 33342 (Invitrogen) and mounted in DAKO fluorescent mounting
medium (Carpinteria, CA, USA).
Samples were imaged on an inverted motorized fluorescent micro-
scope (Olympus, IX81, Tokyo, Japan) with an Orca-R2 Hamamatsu CCD
camera (Hamamatsu, Japan). The camera driver and image acquisition
were controlled with a MetaMorph Imaging System (Olympus). Digital
image files representing three independent experiments were trans-
ferred to Photoshop 7.0/CS5 to assemble montages.
Reagents and antibodies
Control nontargeting shRNA (shC) and TnT3-targeting shRNA (shT) were
purchased from Sigma. Rabbit anti-TnT3 polyclonal antibody was
obtained from Aviva Systems Biology (San Diego, CA, USA); mouse
anti-TnT1 CT3 antibody and mouse anti-Cavb1a from Developmental
Studies Hybridoma Bank (DSHB, Iowa City, IA, USA); and mouse
monoclonal IIF7 to Cav1.1 was a generous gift from Dr. Kevin P.
Campbell (University of Iowa, IA, USA). Mouse antimyosin heavy chain
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(MHC) MF20 was purchased from DSHB, and mouse anti-actin from
Millipore (Billerica, MA, USA). Alexa 488-conjugated anti-mouse and
anti-rabbit IgG were purchased from Invitrogen. NA931V goat anti-
mouse and NA9340V donkey anti-rabbit (Amersham Health, Marlbor-
ough, MA, USA) were used as secondary antibodies for immunoblotting.
BDA-410 administration
Mice were treated daily for 21 days with either 1% Tween 80 in normal
saline (vehicle) or calpain inhibitor BDA-410 [(2S)-N-(1S)-1-[(S)-Hydroxy
(3-oxo-2-phenyl-1-cyclopropen-1-yl)methyl]-2-methylpropyl-2-benzene-
sulfonylamino-4-methylpentanamide], a cyclopropenone derivative syn-
thetized by Mitsubishi Tanabe Pharma Corporation (Yokohama, Japan)
dissolved in vehicle at 30 mg kg1 day1, and received 10 mL kg1 by
oral gavage with a straight 20G feeding needle (Fine Sciences Tools,
Foster City, CA, USA).
In vivo muscle function recording
Force was recorded in the posterior compartment of the right hindlimb
(gastrocnemius, soleus, and plantaris muscles) using an in vivo force
transducer (Aurora Scientific, Aurora, ON, Canada) attached to the
mouse footplate. Mice were anesthetized with 2% inhaled isofluorane
at a constant flow rate of 2 L min1. After removal of the animal’s fur,
the common peroneal nerve was located and an electrode was placed
over the nerve. Resting tension, muscle length, and stimulation current
were iteratively adjusted for each muscle to obtain optimal twitch force.
The nerve was then stimulated to obtain force–frequency curves as
described (Files et al., 2012).
In vivo fatigue recording
In vivo fatigue was recorded before and after treatment using a forced
Exer 6 lane treadmill apparatus (Columbus Instruments, Columbus, OH,
USA), as described (Delbono et al., 2012). On consecutive days, mice
were allowed to run on the treadmill for 5 min at 10 m min1 on days 1
and 2 and 5 min at 10 m min1 followed by 2 m min1 increments
until reaching 20 m min1 for 2 min each period on day 3. The treadmill
was not inclined. After training, mouse performance was recorded. The
initial speed was 10 m min1 to a maximum of 5 min, and then, we
increased the pace by 2 m min1 every 2 min to a maximum of
24 m min1 or until exhaustion. We considered the mouse exhausted
when it remained at least 10 s in the electric shock area of the treadmill.
Maximal tolerated speed was recorded.
Inverted-cling grip test
Grip strength was assessed using Kondziela’s inverted screen test before
and after mouse treatment. This procedure provides a measure of overall
strength and muscular endurance of the mouse. The mice were allowed
to acclimate in the experimental room for 10 min before testing, and the
time they held from the net was computed. The results were the average
of three consecutive trials.
Ex vivo whole muscle contraction
Soleus muscles were dissected, placed in cold Krebs’s solution, and most
of the surrounding connective tissue was removed. Aluminum T-shaped
clips were used to attach the muscle to a 407A force transducer (Aurora
Scientific; compliance: 0.01 lm mN1, resonant frequency: 4.0 kHz)
and a length controller (Gonzalez et al., 2003). The muscle was
continually perfused with buffered recording solution (in mM: NaCl
121, KCl 5, CaCl2 1.8, MgCl2 0.5, NaH2PO4 0.4, NaHCO3 24.0, glucose
5.5, d-tubocurarine chloride hydrate 0.015) bubbled with a mixture of
5% CO2 and 95% O2 to maintain pH 7.4. The muscle was allowed to
balance for 15 min before direct stimulation by an electrical field
generated between two parallel platinum electrodes connected to a
stimulator. The muscle length was adjusted until a single stimulus pulse
or a train of pulses elicited maximum force during twitch or tetanus
(optimal length [Lo]) under isometric conditions. After attaining Lo, the
muscle was allowed to rest for 8 min, and subsequently, the force–
frequency relationship was recorded at 1, 5, 10, 20, 50, 100, and
150 Hz using 400-ms trains of pulses. The interval between trains of
pulses was set according to the duration of the stimulus (0.5–8 min).
Muscle fatigue was recorded in response to 400 ms/150 Hz supramax-
imal pulses applied for a maximum of 5 min. Experiments were
performed at 22 °C. Data were analyzed using ASI600A Digital Controller
software (Aurora).
Skeletal muscle dissection and preparation for protein, RNA
analysis or histology
After in vivo functional recordings, muscles were collected in RNase-free
conditions. Muscles assigned to protein and RNA analysis were snap-
frozen in liquid nitrogen and stored at 80 °C. Muscles for histological
evaluations were fixed in 4% paraformaldehyde at resting length,
cryopreserved by sucrose gradient, embedded in O.C.T compound
(Tissue-Tek, Sakura Finetek, Torrance, CA, USA), frozen in dry ice-
chilled isopentane, and stored at 80 °C.
Muscle cross-sectional area
The muscle cross-sectional area (CSA) was calculated by dividing wet
mass by the product of the fiber length and 1.06 g cm3, the density of
mammalian skeletal muscle (Brooks & Faulkner, 1988). The fiber length
was estimated by multiplying the muscle length at Lo by 0.71, the ratio
between fiber length and muscle length for mouse soleus muscle
(Brooks & Faulkner, 1988). The value of the CSA was later used to
calculate muscle-specific force (Newton cm2).
SDS-polyacrylamide gel electrophoresis (PAGE) and Western
blotting. Methods for FL-TnT and fragments in cellular subcompart-
ments followed described procedures (Zhang et al., 2013b). The frozen
soleus muscles or EDL muscle were cut into small pieces in a tube on dry
ice. SDS-PAGE sample buffer containing 2% SDS and 3% b-mercap-
toethanol, pH 8.8, was added to the tube at 40-fold of the muscle
weight (lL mg1) for homogenizing the muscle tissue using a high-
speed mechanical homogenizer. The SDS-PAGE samples were then
heated at 80 °C for 5 min and centrifuged at 14 000 g in a microcen-
trifuge for 5 min to remove insoluble debris. The supernatant was
resolved on SDS-gels with 14% acrylamide, bisacrylamide at a ratio of
180:1 prepared in a modified Laemmli buffer system, in which both
stacking and resolving gels were at pH 8.8 or 2 ~ 12% gradient gel with
acrylamide, bisacrylamide ratio of 180:1. The resolved protein bands
were visualized by Coomassie Blue R-250 staining. The actin bands were
quantified using ImageJ software (National Institutes of Health, NIH,
Bethesda, MD, USA) to normalize sample loading.
Duplicate SDS-gels were transferred to nitrocellulose membrane using
a Bio-Rad semidry electrical transfer device at constant current of
5 mA cm2 for 15 min. The blotted membranes were blocked with 1%
BSA in Tris-buffered saline (TBS, 150 mM NaCl, 50 mM Tris-HCl, pH 7.5)
at room temperature with shaking for 30 min. The blocked membrane
was probed at 4 °C overnight with anti-TnI monoclonal antibody (mAb)
Calpain, troponin and muscle function with aging, T. Zhang et al.496
ª 2016 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
TnI-1 (Jin et al., 2001), antislow TnT mAb CT3 or antifast TnT mAb T12
(Jin & Chong, 2010) diluted in TBS containing 0.1% BSA. The
membranes were then washed three times for 7 min each with TBS
containing 0.5% Triton X-100 and 0.05% SDS and three times for 3 min
each with TBS before incubation with alkaline phosphatase-labeled goat
anti-mouse IgG second antibody (Santa Cruz Biotechnology, Dallas, TX,
USA) at room temperature for 1 h. The membranes were washed again
and developed in 5-bromo-4-chloro-3-indolyl phosphate/nitro blue
tetrazolium substrate solution to visualize the protein bands recognized
by the specific mAbs.
Myosin heavy chain (MHC) isoforms were examined as described
previously (Feng et al., 2009). SDS-gel sample equal to 5 lg of muscle
tissue was resolved on SDS-polyacrylamide gel with 8% acrylamide,
bisacrylamide at the ratio of 50:1 containing 30% glycerol in an icebox
for 24 h. The gels were stained with Coomassie Blue R250, and the
relative amounts of MHC isoforms were quantified by two-dimensional
densitometry using ImageJ.
Calpain activity
After completion of the 3-week treatmentmicewere sacrificed, hamstring
muscles dissected and snap-frozen in liquid nitrogen. For calpain activity
assay, we followed described methods (Supinski et al., 2009). Briefly,
100 lg protein was added to a buffer containing: 50 mM HEPES, 100 mM
NaCl, 0.1% NaCl, 0.1% CHAPS, 10 mM DTT, 1 mM EDTA, 10% glycerol,
pH: 7.4, and a fluorogenic substrate cleaved by calpain [succinyl-Leu-Leu-
Val-Tyr-7-amido-4-methyl-coumarin (Suc-LLVY-AMC)]. Duplicate deter-
minations were made for each sample using a mixture of gastrocnemius
muscle homogenate, assay buffer, fluorogenic substrate, and highly
specific calpain inhibitor (0.1 mg mL1 calpain inhibitor III, carbobenzoxy-
valinyl-phenylalaninal). Immediately after the addition of the fluorogenic
substrate, a baseline fluorescent measurement of AMC (7-amino-4-
methylcoumarin) was performed using a spectrofluorophotometer (exci-
tation frequency of 360 nm and an emission frequency of 460 nm,
Molecular Devices, Sunnyvale, CA, USA). AMC standards were used to
create a calibration curve, and activity was quantified as nanomoles of
AMC generated per minute per milligram of tissue homogenate protein.
The difference between AMC generation from incubation of homo-
genates with Suc-LLVY-AMC in the presence and absence of calpain
inhibitor III was taken as an index of calpain activity; note that calpain
inhibitor III blocks calpain activity but does not inhibit the proteasome or
other chymotrypsin-like proteases (Supinski et al., 2009).
Statistical analysis
Data were analyzed using SIGMAPLOT 12.5 (Systat Software, San Jose, CA,
USA) or PRISM 5.0a (GraphPad Software, Inc., La Jolla, CA, USA). All data
are presented as means  SEM and reported P values are the result of
one-sided tests. The alpha level was set at P < 0.05. Student’s t-test or
analysis of variance (ANOVA) was used to compare experimental groups
where appropriate.
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